PEG-asparaginase in treatment of childhood acute lymphoblastic leukemia
- Author
- Veerle Mondelaers (UGent) , Tieneke Bauters (UGent) , Barbara De Moerloose (UGent) and Yves Benoit
- Organization
Downloads
-
(...).pdf
- full text
- |
- UGent only
- |
- |
- 110.67 KB
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-4217781
- MLA
- Mondelaers, Veerle, et al. “PEG-Asparaginase in Treatment of Childhood Acute Lymphoblastic Leukemia.” BELGIAN JOURNAL OF HEMATOLOGY, vol. 4, no. 4, 2013, pp. 138–43.
- APA
- Mondelaers, V., Bauters, T., De Moerloose, B., & Benoit, Y. (2013). PEG-asparaginase in treatment of childhood acute lymphoblastic leukemia. BELGIAN JOURNAL OF HEMATOLOGY, 4(4), 138–143.
- Chicago author-date
- Mondelaers, Veerle, Tieneke Bauters, Barbara De Moerloose, and Yves Benoit. 2013. “PEG-Asparaginase in Treatment of Childhood Acute Lymphoblastic Leukemia.” BELGIAN JOURNAL OF HEMATOLOGY 4 (4): 138–43.
- Chicago author-date (all authors)
- Mondelaers, Veerle, Tieneke Bauters, Barbara De Moerloose, and Yves Benoit. 2013. “PEG-Asparaginase in Treatment of Childhood Acute Lymphoblastic Leukemia.” BELGIAN JOURNAL OF HEMATOLOGY 4 (4): 138–143.
- Vancouver
- 1.Mondelaers V, Bauters T, De Moerloose B, Benoit Y. PEG-asparaginase in treatment of childhood acute lymphoblastic leukemia. BELGIAN JOURNAL OF HEMATOLOGY. 2013;4(4):138–43.
- IEEE
- [1]V. Mondelaers, T. Bauters, B. De Moerloose, and Y. Benoit, “PEG-asparaginase in treatment of childhood acute lymphoblastic leukemia,” BELGIAN JOURNAL OF HEMATOLOGY, vol. 4, no. 4, pp. 138–143, 2013.
@article{4217781, author = {{Mondelaers, Veerle and Bauters, Tieneke and De Moerloose, Barbara and Benoit, Yves}}, issn = {{2033-3749}}, journal = {{BELGIAN JOURNAL OF HEMATOLOGY}}, language = {{eng}}, number = {{4}}, pages = {{138--143}}, title = {{PEG-asparaginase in treatment of childhood acute lymphoblastic leukemia}}, volume = {{4}}, year = {{2013}}, }